Arbutus Biopharma Corp Increase (Decrease) in Accounts Payable and Accrued Liabilities
Arbutus Biopharma Corp (ABUS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-12
CAD
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|
| 2012-12-31 | -196.26K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -2.18M CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 498.10K CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 1.18M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.61M 10-Q · filed 2026-08-12 | -$1.80M derived: sum of 3 quarters · filed 2026-08-12 | -$1.66M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | -$985.00K 10-Q · filed 2026-05-13 | -$179.00K derived: sum of 2 quarters · filed 2026-05-13 | -$34.00K derived: sum of 3 quarters · filed 2026-05-13 | -$7.63M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $806.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $951.00K derived: sum of 2 quarters · filed 2026-03-23 | -$6.65M derived: sum of 3 quarters · filed 2026-08-12 | -$2.10M 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$7.46M derived: sum of 2 quarters · filed 2026-08-12 | -$2.91M 10-Q · filed 2025-11-13 | -$2.89M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.06M 10-Q · filed 2026-08-12 | -$3.04M derived: sum of 3 quarters · filed 2026-08-12 | -$6.60M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $4.54M 10-Q · filed 2026-05-13 | $4.57M derived: sum of 2 quarters · filed 2026-05-13 | $1.00M derived: sum of 3 quarters · filed 2026-05-13 | $3.86M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$3.54M derived: sum of 2 quarters · filed 2026-03-23 | -$683.00K derived: sum of 3 quarters · filed 2026-03-23 | -$2.71M 10-K · filed 2026-03-23 | |||
| 2024-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$703.00K derived: sum of 2 quarters · filed 2025-11-13 | -$2.73M 10-Q · filed 2025-11-13 | -$2.26M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $837.00K 10-Q · filed 2025-08-06 | $1.30M derived: sum of 3 quarters · filed 2025-08-06 | $2.30M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | -$2.02M 10-Q · filed 2025-05-14 | -$1.56M derived: sum of 2 quarters · filed 2025-05-14 | -$558.00K derived: sum of 3 quarters · filed 2025-05-14 | -$1.41M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.47M derived: sum of 2 quarters · filed 2025-03-27 | $618.00K derived: sum of 3 quarters · filed 2025-03-27 | -$5.76M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $153.00K derived: sum of 2 quarters · filed 2024-11-06 | -$6.22M 10-Q · filed 2024-11-06 | -$2.46M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$7.22M 10-Q · filed 2024-08-08 | -$3.46M derived: sum of 3 quarters · filed 2024-08-08 | -$3.67M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$6.38M 10-Q · filed 2024-05-02 | -$2.62M derived: sum of 2 quarters · filed 2024-05-02 | -$2.82M derived: sum of 3 quarters · filed 2024-05-02 | $942.00K derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $3.56M derived: sum of 2 quarters · filed 2024-03-05 | $7.32M derived: sum of 3 quarters · filed 2024-03-05 | $5.22M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.56M derived: sum of 2 quarters · filed 2023-11-07 | $1.46M 10-Q · filed 2023-11-07 | $2.78M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.66M 10-Q · filed 2023-08-03 | $2.99M derived: sum of 3 quarters · filed 2023-08-03 | $4.15M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$2.10M 10-Q · filed 2023-05-04 | -$776.00K derived: sum of 2 quarters · filed 2023-05-04 | $391.00K derived: sum of 3 quarters · filed 2023-05-04 | $2.60M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $2.49M derived: sum of 2 quarters · filed 2023-03-02 | $4.71M derived: sum of 3 quarters · filed 2023-03-02 | $1.91M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.38M derived: sum of 2 quarters · filed 2022-11-09 | $585.00K 10-Q · filed 2022-11-09 | $2.40M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$582.00K 10-Q · filed 2022-08-04 | $1.23M derived: sum of 3 quarters · filed 2022-08-04 | $2.48M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | -$2.80M 10-Q · filed 2022-05-05 | -$983.00K derived: sum of 2 quarters · filed 2022-05-05 | $268.00K derived: sum of 3 quarters · filed 2022-05-05 | $2.47M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $3.06M derived: sum of 2 quarters · filed 2022-03-03 | $5.27M derived: sum of 3 quarters · filed 2022-03-03 | $1.67M 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.46M derived: sum of 2 quarters · filed 2021-11-04 | -$147.00K 10-Q · filed 2021-11-04 | -$2.14M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.40M 10-Q · filed 2021-08-05 | -$3.39M derived: sum of 3 quarters · filed 2021-08-05 | -$2.85M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | -$3.60M 10-Q · filed 2021-05-05 | -$5.60M derived: sum of 2 quarters · filed 2021-05-05 | -$5.06M derived: sum of 3 quarters · filed 2021-05-05 | -$4.17M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$1.46M derived: sum of 2 quarters · filed 2021-03-04 | -$568.00K derived: sum of 3 quarters · filed 2021-03-04 | -$3.31M 10-K · filed 2021-03-04 | -$2.41M 10-K · filed 2020-03-05 | ||
| 2019-09-30 | $538.00K 10-Q · filed 2019-11-06 | $1.43M derived: sum of 2 quarters · filed 2019-11-06 | -$1.32M 10-Q · filed 2020-11-05 | -$554.00K derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2019-06-30 | $888.00K 10-Q · filed 2019-08-05 | -$2.64M 10-Q · filed 2020-08-07 | -$1.86M 10-Q · filed 2019-08-05 | -$1.09M derived: sum of 3 quarters · filed 2020-05-11 | $2.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-03-31 | -$2.88M 10-Q · filed 2020-05-11 | -$2.75M 10-Q · filed 2019-05-06 | -$1.98M derived: sum of 2 quarters · filed 2020-05-11 | -$886.00K derived: sum of 3 quarters · filed 2020-05-11 | $35.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $2.00M derived: sum of 2 quarters · filed 2020-03-05 | $2.92M derived: sum of 3 quarters · filed 2020-03-05 | -$1.27M 10-K · filed 2020-03-05 | |||
| 2018-09-30 | $1.09M 10-Q · filed 2019-11-06 | $2.02M derived: sum of 2 quarters · filed 2019-11-06 | -$2.17M 10-Q · filed 2019-11-06 | $2.08M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $921.00K 10-Q · filed 2019-08-05 | -$3.27M 10-Q · filed 2019-08-05 | $983.00K derived: sum of 3 quarters · filed 2019-08-05 | -$822.00K derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2018-03-31 | -$4.19M 10-Q · filed 2019-05-06 | $62.00K derived: sum of 2 quarters · filed 2019-05-06 | -$1.74M derived: sum of 3 quarters · filed 2019-05-06 | $462.00K derived: sum of 4 quarters · filed 2019-05-06 | |||
| 2017-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.44M derived: sum of 2 quarters · filed 2019-03-07 | $4.65M derived: sum of 3 quarters · filed 2019-03-07 | $736.00K 10-K · filed 2019-03-07 | |||
| 2017-09-30 | -$1.80M 10-Q · filed 2018-11-07 | $400.00K derived: sum of 2 quarters · filed 2018-11-07 | -$3.51M 10-Q · filed 2018-11-07 | -$1.52M derived: sum of 4 quarters · filed 2018-11-07 | |||
| 2017-06-30 | $2.21M 10-Q · filed 2018-08-03 | -$1.71M 10-Q · filed 2018-08-03 | $283.00K derived: sum of 3 quarters · filed 2018-08-03 | -$604.00K derived: sum of 4 quarters · filed 2018-08-03 | |||
| 2017-03-31 | -$3.91M 10-Q · filed 2018-05-04 | -$1.92M derived: sum of 2 quarters · filed 2018-05-04 | -$2.81M derived: sum of 3 quarters · filed 2018-05-04 | -$2.77M derived: sum of 4 quarters · filed 2018-05-04 | |||
| 2016-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.10M derived: sum of 2 quarters · filed 2018-03-16 | $1.14M derived: sum of 3 quarters · filed 2018-03-16 | $26.00K 10-K · filed 2018-03-16 | |||
| 2016-09-30 | -$887.00K 10-Q · filed 2017-11-02 | -$845.00K derived: sum of 2 quarters · filed 2017-11-02 | -$1.96M 10-Q · filed 2017-11-02 | -$1.51M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-06-30 | $42.00K 10-Q · filed 2017-08-03 | -$1.07M 10-Q · filed 2017-08-03 | -$628.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.78M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-03-31 | -$1.12M 10-Q · filed 2017-05-04 | -$670.00K derived: sum of 2 quarters · filed 2018-03-16 | $1.74M derived: sum of 3 quarters · filed 2018-03-16 | -$5.61M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2015-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.85M derived: sum of 2 quarters · filed 2018-03-16 | -$4.50M derived: sum of 3 quarters · filed 2018-03-16 | -$2.49M 10-K · filed 2018-03-16 | |||
| 2015-09-30 | $2.41M 10-Q · filed 2016-11-03 | -$4.94M derived: sum of 2 quarters · filed 2016-11-03 | -$2.94M 10-Q · filed 2016-11-03 | $853.00K derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2015-06-30 | -$7.35M 10-Q · filed 2016-08-04 | -$5.34M 10-Q · filed 2016-08-04 | -$1.55M derived: sum of 3 quarters · filed 2017-03-22 | $802.00K derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2015-03-31 | $2.01M 10-Q · filed 2016-05-04 | $5.80M derived: sum of 2 quarters · filed 2017-03-22 | $8.15M derived: sum of 3 quarters · filed 2017-03-22 | $7.21M derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2014-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $6.14M derived: sum of 2 quarters · filed 2017-03-22 | $5.20M derived: sum of 3 quarters · filed 2017-03-22 | $6.25M 10-K · filed 2017-03-22 | |||
| 2014-09-30 | $2.36M 10-Q · filed 2015-11-05 | $1.41M derived: sum of 2 quarters · filed 2015-11-05 | $2.46M 10-Q · filed 2015-11-05 | $1.98M derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2014-06-30 | -$943.00K 10-Q · filed 2015-08-07 | $108.00K 10-Q · filed 2015-08-07 | -$380.00K derived: sum of 3 quarters · filed 2016-03-09 | -$1.10M derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2014-03-31 | $1.05M 10-Q · filed 2015-05-06 | $563.00K derived: sum of 2 quarters · filed 2016-03-09 | -$161.00K derived: sum of 3 quarters · filed 2016-03-09 | -$885.00K derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2013-12-31 | -$488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$1.21M derived: sum of 2 quarters · filed 2016-03-09 | -$1.94M derived: sum of 3 quarters · filed 2016-03-09 | $130.00K 10-K · filed 2016-03-09 | $130.00K 6-K · filed 2014-03-06 | ||
| 2013-09-30 | -$724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$1.45M derived: sum of 2 quarters · filed 2014-11-07 | $618.00K 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | -$724.00K 10-Q · filed 2014-11-07 | $535.00K 10-Q · filed 2014-08-14 | $1.34M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $807.00K 10-Q · filed 2014-05-14 | ||||||
| 2012-12-31 | -$197.00K 10-K · filed 2015-03-13 | -$197.26K 6-K · filed 2014-03-06 | |||||
| 2011-12-31 | -$2.14M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |